Calcivis Revenue and Competitors

CALCIVIS is an innovative dental biologic and device manufacturer focused on revolutionizing treatment of tooth decay and enabling preventive dentistry. With a US presence and global headquarters in Edinburgh, Scotland, CALCIVIS brings world-class development and business management expertise to a sector eager to reduce reliance on costly, complex and painful surgical interventions. Having gained FDA approval, we are excited to now offer this cutting-edge technology to clinicians in the United States!\n\nCALCIVIS is focused on revolutionizing the management of dental demineralization by providing what leading clinicians consider to be the “Holy Grail” of cariology (tooth decay): real-time chairside assessment of the caries disease process.\n\nInformation about activity of enamel demineralization has not been available previously and enables the preventive dentistry approach.\n\nBy supporting early decision making and improving patient communication, compliance with oral health advice increases and consent for prescribed treatment improves leading to enhanced clinical and professional outcomes.